Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.

about

Epothilone B induces apoptosis and enhances apoptotic effects of ABT-737 on human cancer cells via PI3K/AKT/mTOR pathway.Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.

P2860

Q38748411-35B19156-082C-4038-A7BF-5450F4F3BC70 Q45070718-C3A02574-7C5F-459A-9774-2B3A09890A72

P2860

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.

Item

http://www.wikidata.org/entity/Q35997562

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Epothilones in epithelial ovar ...... l cancer: a systematic review.

@ast

Epothilones in epithelial ovar ...... l cancer: a systematic review.

@en

type

Item

label

Epothilones in epithelial ovar ...... l cancer: a systematic review.

@ast

Epothilones in epithelial ovar ...... l cancer: a systematic review.

@en

prefLabel

Epothilones in epithelial ovar ...... l cancer: a systematic review.

@ast

Epothilones in epithelial ovar ...... l cancer: a systematic review.

@en

P1476

Epothilones in epithelial ovar ...... al cancer: a systematic review

@en

P2093

Aristotle Bamias

http://www.w3.org/2001/XMLSchema#string

Dimosthenis Chrysikos

http://www.w3.org/2001/XMLSchema#string

Flora Zagouri

http://www.w3.org/2001/XMLSchema#string

Theodoros N Sergentanis

http://www.w3.org/2001/XMLSchema#string

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas

Phase II clinical trial of ixabepilone in patients with recurrent or persistent platinum- and taxane-resistant ovarian or primary peritoneal cancer: a gynecologic oncology group study.

A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors.

Epothilones and related structures--a new class of microtubule inhibitors with potent in vivo antitumor activity.

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary.

Novel molecules that interact with microtubules and have functional activity similar to Taxol.

Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer.

The epothilones and related analogues-a review of their syntheses and anti-cancer activities.

P304

2187-2198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S77342

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Meletios A. Dimopoulos

P577

2015-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26316786

http://www.w3.org/2001/XMLSchema#string

P921

fallopian tube

patupilone

P932

4550178

http://www.w3.org/2001/XMLSchema#string

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.

about

P2860

P2860

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932